주식/증권
📈 긍정적
Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
요약
ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.